Revance Therapeutics, Inc.
RVNC
Revenue
65.39M
▲13.45M▲25.90%
3 Months ChangeAssets
494.80M
▼-13.32M▼-2.62%
3 Months ChangeLiabilities
624.54M
▲17.75M▲2.92%
3 Months ChangeFree Cash Flow
-67.65M
▲2.72M▲3.86%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001140361-24-044892
2024-10-28
Form 8-K
ID: 0001140361-24-044317
2024-10-18
Form 8-K
ID: 0001140361-24-043670
2024-10-04
Form 8-K
ID: 0001140361-24-042816
2024-09-23
Form 8-K
ID: 0001140361-24-041600
2024-09-09
Form 8-K
ID: 0001479290-24-000120
2024-08-28
Form 8-K
ID: 0001479290-24-000118
2024-08-12
Form 8-K
ID: 0001193125-24-198448
2024-08-09
Form 8-K
ID: 0001479290-24-000114
2024-08-08
Form 10-Q
ID: 0001479290-24-000111